Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

948 recalls · Class II, newest first

Class II · Moderate risk

Gynazole-1

Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.

Ongoing cGMP deviation Padagis US LLC D-0081-2024
Class II · Moderate risk

fentaNYL

Lack of assurance of sterility:

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-0025-2024
Class II · Moderate risk

fentaNYL

Lack of assurance of sterility:

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-0023-2024
Class II · Moderate risk

fentaNYL

Lack of assurance of sterility:

Terminated Sterility / contamination Central Admixture Pharmacy Services Inc D-0022-2024

Recalls by year